What the world needs now: an institute for chylothorax research

I know I have mentioned this to various people, but I finally wanted to write down what was on my mind. Two weeks ago we attended the funeral of one of Peter's little intensive care buddies. Totally different medical situation, but chylothorax was one of the major factors in that baby's struggle.

Chylothorax is a leakage of chyle (fluid from the lymphatic system) into the thoracic cavity. It is often triggered by thoracic surgery, such as open-heart surgery, but can occur spontaneously. It happens in infants and adults, and even in cats and dogs--just google 'chylothorax' and you get a lot of veterinary links. The lymphatic system, in addition to its infection-fighting job, also processes fats in the bloodstream. With chylothorax, the fats get dumped along with chyle into the chest cavity, putting pressure on the heart and lungs.

When Peter's chylothorax started a few days after his heart surgery, the surgeon explained what it was and listed the treatment options. He said, "From the variety of treatments you may rightly conclude that this condition is not well understood." The treatment protocol included removing all fats from the diet, an IV medication called Octreotide, a surgical procedure called pleurodesis, and using the ventilator settings to hyperexpand the patient's lungs against the rib cage. After the effusions stop, the patient must continue on a fat-free diet for three months, then gradually reintroduce fats.

Peter underwent all these treatments. It still took almost two months for the effusions to subside. Children who have heart defects requiring multiple surgeries could get chylothorax, then recover, then get it again after the next surgery. In all that time, an infant with this condition cannot have the fats its body needs to grow and develop. Proteins are washed out along with the fats, and thyroid deficiencies can arise. Chest tubes must be inserted to drain the effusions, but this limits movement and motor development. The domino effect of chylothorax is considerable.

Even from the insurance company's perspective, the cost of chylothorax is high. Peter's hospital stay was originally estimated at four weeks, but ended up at four months--because of chylothorax. As long as the effusions continued, he was in intensive care. He required chest X-rays every day or two, and plasma transfusions on a regular basis to replace lost fluids. Octreotide is an expensive drug, I am told. Then there was the pleurodesis (another surgery), and the need for a tracheostomy (surgery again) because of the long-term ventilator dependency. His custom trach tubes cost more than...well, never mind. And when Peter was ready to come home, he needed 24-hour nursing care and the support of a medical supply and service company.

Surely this condition is worthy of concentrated study. If Michel and I had millions, this is what we would do with it: we would found an institute for chylothorax research. It would be associated with a large hospital that saw a fair number of chylothorax patients every year. The work of this institute would be to come to an understanding of the condition while also working on treatments/prevention. There might be a veterinary wing or branch, because surely there must be correspondences between chylothorax in humans and the same condition in animals. An annual conference would be held to bring together the best new thinking from all over the world. There would also be a nutrition division to come up with healthy, palatable foods for chylothorax patients, especially babies. Peter enjoyed specially-defatted donor breast milk from the Denver Breast Milk Bank; some similar processing center might be part of the institute. There would also be counselling and support for parents and family of chylothorax patients.

We praise God that Peter's chylothorax is a thing of the past. We wish it could be a thing of the past for everyone.

There will be an update on Peter in a day or two. He is doing very well, by the way!